VP, Market Access & Value Strategy

Neurogene; Houston (TX); A distancia; USD 350.000 - 550.000; Jornada completa

Descripción de la vacante

Neurogene is seeking a Vice President of Market Access to lead the U.S. strategy for NGN-401 and future gene therapies. You will own payer engagement, reimbursement pathways, pricing, and institutional access, reporting to the Chief Commercial Officer.

This role requires deep expertise in rare-disease commercialization and CMS/payer dynamics. You will build scalable market access capabilities, shape launch readiness, and influence policy at national levels to ensure patient access to high-cost

Formación

• 15+ years progressive leadership in market access/pharma/biotech.
• Experience launching/ commercializing rare disease therapies.
• Deep understanding of US healthcare reimbursement: commercial payers, Medicaid, gov programs.
• Experience with institutional reimbursement, hospital economics, coding, payment pathways.
• Ability to build and lead high-performing teams.

Responsabilidades

• Develop integrated US market access strategy for NGN-401 and future therapies.
• Lead payer engagement, government programs, contracting, and value demonstration.
• Establish launch-readiness milestones and risk mitigation.
• Partner across Commercial, Medical Affairs, Finance, Regulatory, Legal.
• Provide strategic recommendations on access-related financial risks and opportunities.

Conocimientos

Payer dynamics

Reimbursement pathways

Executive leadership

Pricing strategy

Contracting

HEOR & value demonstration

Cross-functional collaboration

Strategic market access

Educación

Bachelor's degree in business, life sciences, healthcare, economics, or related field

Advanced degree in business, healthcare, public health, economics, or related discipline (plus)

Descripción del empleo

Neurogene is seeking a Vice President of Market Access to lead the U.S. strategy for NGN-401 and future gene therapies. You will own payer engagement, reimbursement pathways, pricing, and institutional access, reporting to the Chief Commercial Officer.

This role requires deep expertise in rare-disease commercialization and CMS/payer dynamics. You will build scalable market access capabilities, shape launch readiness, and influence policy at national levels to ensure patient access to high-cost